The frequency of chimeric expression pattern found in bladder tumours suggests that intra-tumour genomic evolution commonly involves loss of STAG2, even in low-grade, low-stage tumours, which are generally considered to represent an evolutionarily stable sub-group. This evidence concerns the gene STAG2 and urinary bladder neoplasm.